![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 35, 27406-27413, September 1, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of § Medicine and Pathology,
Huffington Center on Aging, Baylor College of Medicine,
Houston, Texas 77030
Lipopolysacharide (LPS) induced acute phase
response (APR) in mouse liver leads to elevation of the low molecular
weight CCAAT/Enhancer binding protein (C/EBP)
Translational Induction of Liver-enriched Transcriptional
Inhibitory Protein during Acute Phase Response Leads to
Repression of CCAAT/Enhancer Binding Protein
mRNA*
,
isoform,
liver-enriched transcriptional inhibitory protein (LIP). In this paper,
we investigate the pathway for LIP induction during APR and the role of
LIP in regulation of the C/EBP
promoter. The 5' region of C/EBP
mRNA has been shown to be involved in the regulation of LIP
translation. Our data demonstrate that binding of cytoplasmic proteins
to the 5' region of C/EBP
mRNA is altered in response to LPS
administration. One of the major changes is induced binding of a
cytoplasmic protein that is immunologically identical to the previously
characterized RNA-binding protein CUGBP1. Induction of CUGBP1 binding
activity in liver cytoplasm during APR is accompanied by the elevation of CUGBP1 binding activity on polysomes. CUGBP1 immunoprecipitated from
livers of LPS-treated mice, but not from normal animals, is capable of
inducing LIP translation in a cell-free translation system. The ability
of CUGBP1 to induce LIP translation during APR depends on
phosphorylation of CUGBP1. We show that elevation of LIP during APR and
after partial hepatectomy leads to increased binding of LIP to
the C/EBP consensus site found within the mouse C/EBP
promoter. This
binding correlates with reduction of C/EBP
mRNA levels in both
biological situations. Co-transfection experiments showed that
full-length C/EBP
activates the C/EBP
promoter, while LIP blocks
this activation. Our data suggest that the dominant negative isoform of
C/EBP
, LIP, down-regulates the C/EBP
promoter in liver and in
cultured hepatocytes. Because full-length C/EBP
and C/EBP
proteins regulate liver proliferation, this function of LIP may be
important in liver growth and differentiation.
*
This work was supported in part by National Institutes of
Health Grants AR10D44387-01 (to L. T. T.), AG00756 (to
N. A. T.), GM55188 (to N. A. T.), and DK53045 (to
G. J. D.), and the Muscular Dystrophy Association (to L. T. T.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by the Training Program in Molecular Endocrinology Grant DK07696.
¶
To whom correspondence should be addressed: Huffington
Center on Aging, N803, Baylor College of Medicine, One Baylor
Plaza, Houston, TX 77030. Tel.: 713-798-1567; Fax: 713-798-4161;
E-mail: nikolait@bcm.tmc.edu.
This article has been cited by other articles:
![]() |
J. M. Dudaronek, S. A. Barber, and J. E. Clements CUGBP1 Is Required for IFNbeta-Mediated Induction of Dominant-Negative CEBPbeta and Suppression of SIV Replication in Macrophages J. Immunol., December 1, 2007; 179(11): 7262 - 7269. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Timchenko, E. Salisbury, G.-L. Wang, H. Nguyen, J. H. Albrecht, J. W. B. Hershey, and N. A. Timchenko Age-specific CUGBP1-eIF2 Complex Increases Translation of CCAAT/Enhancer-binding Protein beta in Old Liver J. Biol. Chem., October 27, 2006; 281(43): 32806 - 32819. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Karagiannides, T. Thomou, T. Tchkonia, T. Pirtskhalava, K. E. Kypreos, A. Cartwright, G. Dalagiorgou, T. L. Lash, S. R. Farmer, N. A. Timchenko, et al. Increased CUG Triplet Repeat-binding Protein-1 Predisposes to Impaired Adipogenesis with Aging J. Biol. Chem., August 11, 2006; 281(32): 23025 - 23033. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Wigmore, K. C. H. Fearon, J. A. Ross, S. J. McNally, W. J. Welch, and O. J. Garden Febrile-range temperature but not heat shock augments the acute phase response to interleukin-6 in human hepatoma cells Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G903 - G911. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Bae and S. G. Kim Enhanced CCAAT/Enhancer-Binding Protein {beta}-Liver-Enriched Inhibitory Protein Production by Oltipraz, Which Accompanies CUG Repeat-Binding Protein-1 (CUGBP1) RNA-Binding Protein Activation, Leads to Inhibition of Preadipocyte Differentiation Mol. Pharmacol., September 1, 2005; 68(3): 660 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-P. Kuang and R. H. Goldstein Regulation of elastin gene transcription by proteasome dysfunction Am J Physiol Cell Physiol, September 1, 2005; 289(3): C766 - C773. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Martinez-Jimenez, M. J. Gomez-Lechon, J. V. Castell, and R. Jover Transcriptional Regulation of the Human Hepatic CYP3A4: Identification of a New Distal Enhancer Region Responsive to CCAAT/Enhancer-Binding Protein {beta} Isoforms (Liver Activating Protein and Liver Inhibitory Protein) Mol. Pharmacol., June 1, 2005; 67(6): 2088 - 2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Timchenko, G.-L. Wang, and L. T. Timchenko RNA CUG-binding Protein 1 Increases Translation of 20-kDa Isoform of CCAAT/Enhancer-binding Protein {beta} by Interacting with the {alpha} and {beta} Subunits of Eukaryotic Initiation Translation Factor 2 J. Biol. Chem., May 27, 2005; 280(21): 20549 - 20557. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schrem, J. Klempnauer, and J. Borlak Liver-Enriched Transcription Factors in Liver Function and Development. Part II: the C/EBPs and D Site-Binding Protein in Cell Cycle Control, Carcinogenesis, Circadian Gene Regulation, Liver Regeneration, Apoptosis, and Liver-Specific Gene Regulation Pharmacol. Rev., June 1, 2004; 56(2): 291 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Baldwin, N. A. Timchenko, and C. A. Zahnow Epidermal Growth Factor Receptor Stimulation Activates the RNA Binding Protein CUG-BP1 and Increases Expression of C/EBP{beta}-LIP in Mammary Epithelial Cells Mol. Cell. Biol., May 1, 2004; 24(9): 3682 - 3691. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kino, D. Mori, Y. Oma, Y. Takeshita, N. Sasagawa, and S. Ishiura Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats Hum. Mol. Genet., March 1, 2004; 13(5): 495 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Foka, S. A. Irvine, F. Kockar, and D. P. Ramji Interleukin-6 represses the transcription of the CCAAT/enhancer binding protein-{alpha} gene in hepatoma cells by inhibiting its ability to autoactivate the proximal promoter region Nucleic Acids Res., December 1, 2003; 31(23): 6722 - 6732. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gangneux, M. Daveau, M. Hiron, C. Derambure, J. Papaconstantinou, and J.-P. Salier The inflammation-induced down-regulation of plasma Fetuin-A ({alpha}2HS-Glycoprotein) in liver results from the loss of interaction between long C/EBP isoforms at two neighbouring binding sites Nucleic Acids Res., October 15, 2003; 31(20): 5957 - 5970. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rodriguez-Antona, R. Bort, R. Jover, N. Tindberg, M. Ingelman-Sundberg, M. J. Gomez-Lechon, and J. V. Castell Transcriptional Regulation of Human CYP3A4 Basal Expression by CCAAT Enhancer-Binding Protein alpha and Hepatocyte Nuclear Factor-3gamma Mol. Pharmacol., May 1, 2003; 63(5): 1180 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Timchenko, P. Iakova, A. L. Welm, Z.-J. Cai, and N. A. Timchenko Calreticulin Interacts with C/EBP{alpha} and C/EBP{beta} mRNAs and Represses Translation of C/EBP Proteins Mol. Cell. Biol., October 15, 2002; 22(20): 7242 - 7257. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Chiu, Y.-G. Tsay, C.-J. Chang, and S.-C. Lee Nopp140 Is a Mediator of the Protein Kinase A Signaling Pathway That Activates the Acute Phase Response alpha 1-Acid Glycoprotein Gene J. Biol. Chem., October 11, 2002; 277(42): 39102 - 39111. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Timchenko, P. Iakova, Z.-J. Cai, J. R. Smith, and L. T. Timchenko Molecular Basis for Impaired Muscle Differentiation in Myotonic Dystrophy Mol. Cell. Biol., October 15, 2001; 21(20): 6927 - 6938. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hirai, D. Radisky, R. Boudreau, M. Simian, M. E. Stevens, Y. Oka, K. Takebe, S. Niwa, and M. J. Bissell Epimorphin Mediates Mammary Luminal Morphogenesis through Control of C/EBP{beta} J. Cell Biol., May 14, 2001; 153(4): 785 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Timchenko, Z.-J. Cai, A. L. Welm, S. Reddy, T. Ashizawa, and L. T. Timchenko RNA CUG Repeats Sequester CUGBP1 and Alter Protein Levels and Activity of CUGBP1 J. Biol. Chem., March 9, 2001; 276(11): 7820 - 7826. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Saunders, L. Sansores-Garcia, D. W. Gilroy, and K. K. Wu Selective Suppression of CCAAT/Enhancer-binding Protein beta Binding and Cyclooxygenase-2 Promoter Activity by Sodium Salicylate in Quiescent Human Fibroblasts J. Biol. Chem., May 25, 2001; 276(22): 18897 - 18904. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |